Want to see HK:2137 full AI Analyst Report?
Brii Biosciences Limited (2137) Income Statement
Brii Biosciences Limited Income Statement
Last quarter (Q2 2026), Brii Biosciences Limited's total revenue was $0.00, a decrease of 100.00% from the same quarter last year. In Q2, Brii Biosciences Limited's net income was $-99.17M. See Brii Biosciences Limited’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 18.12M | $ 54.29M | $ 56.32M | $ 51.63M | $ 92.54M | |
| $ 0.00 | $ 54.29M | $ 56.32M | $ 51.63M | $ 92.54M | |
| $ 310.26M | $ 453.79M | $ 600.62M | $ 565.81M | $ 703.02M | |
| Depreciation and Amortization | $ 5.59M | $ 8.85M | $ 15.67M | $ 17.03M | $ 17.26M |
| $ -290.29M | $ -390.65M | $ -168.20M | $ -496.81M | $ -593.22M | |
| $ -295.88M | $ -399.50M | $ -544.30M | $ -513.85M | $ -610.48M | |
| $ 79.47M | $ -112.88M | $ 359.93M | $ 24.06M | $ -3.58B | |
| $ -216.42M | $ -512.38M | $ -184.37M | $ -489.78M | $ -4.19B | |
| $ -216.86M | $ -508.16M | $ -174.83M | $ -484.31M | $ -4.12B | |
| Per Share Metrics | |||||
| Basic EPS | $ -0.30 | $ -0.70 | $ -0.24 | $ -0.67 | $ -9.48 |
| Diluted EPS | $ -0.30 | $ -0.70 | $ -0.24 | $ -0.67 | $ -9.48 |
| Weighted Average Shares Outstanding | 721.87M | 730.25M | 728.10M | 723.48M | 439.05M |
| Weighted Average Shares Outstanding (Diluted) | 721.87M | 730.25M | 728.10M | 723.48M | 439.05M |
Currency in CNY